Cantor Fitzgerald cuts Informatica price target to $18 from $29
Cantor Fitzgerald adjusted its outlook on Informatica (NYSE:INFA) shares by lowering the price target to $18.00 from the ...
Phathom Pharmaceuticals initiated at Cantor Fitzgerald on ‘significant’ upside
Cantor Fitzgerald initiated coverage of Phathom Pharmaceuticals (PHAT) with an Overweight rating and $23 price target The firm cited ...
Phathom Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage of Phathom Pharmaceuticals (PHAT) with an Overweight rating and $23 price target Maximize Your Portfolio ...
Cantor Fitzgerald Investment Advisors L.P. Trims Stake in Meta Platforms, Inc. (NASDAQ:META)
Cantor Fitzgerald Investment Advisors L.P. decreased its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 1.6% in the fourth quarter, according to its most recent 13F filing with ...
Seabridge Gold Announces US$100 Million in Financings Includes US$20 million from Strategic Investor
Seabridge Gold Inc. (TSX: SEA) (NYSE: SA) ("Seabridge" or the "Company") announced today it has entered into an agreement with RBC Capital Markets and Cantor Fitzgerald Canada Corporation (together ...
Cantor Fitzgerald Raises Freshworks Inc. (FRSH) Price Target, Citing AI Growth and Enterprise Expansion
We recently compiled a list of the 10 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...
Benzinga.com8d
Strategy (Ex-MicroStrategy) With Bullish Outlook, But Challenges Remain: Report
Analysts emphasize Strategy’s Bitcoin acquisitions, capital raises, and accounting rule changes impacting financial reporting ...
Rejuvenation of a Sharp Employer Non-Compete Tool: Delaware Supreme Court Reinvigorates the Employee Choice Doctrine
The authors write "Post-employment restrictive covenants, once viewed as near fortresses to protect proprietary information, ...
Senate panel advances Lutnick for Commerce secretary
The Senate Commerce, Science and Transportation Committee advanced Howard Lutnick’s nomination to lead the Commerce ...
Vanda Pharmaceuticals And Anaptys Announce Exclusive Global License Agreement For Vanda To Develop And Commercialize Imsidolimab, An IL-36R Antagonist
Imsidolimab inhibits the function of the IL-36R, compensating for the deficiency of the endogenous IL-36 regulator in patients with GPP. Imsidolimab has successfully concluded its development program ...
bnnbloomberg14d
Stablecoin Issuer Tether Says Profit Was $13 Billion Last Year
During the hearing, Lutnick disclosed that Cantor Fitzgerald has a convertible bond with Tether, and he said that stablecoins denominated in dollars should be audited. Closely-held Tether doesn’t ...
Investing14d
Cantor Fitzgerald maintains Cipher Mining Overweight rating
On Friday, Cantor Fitzgerald reaffirmed its Overweight rating on Cipher ... The $11.00 price target suggests a level of confidence in the company's future financial performance and growth prospects.